Adjuvant Endocrine Therapy

What endocrine therapy, if any, would you recommend for a 55-year-old postmenopausal woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes?

What endocrine therapy, if any, would you recommend for a 55-year-old postmenopausal woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes?

What endocrine therapy, if any, would you recommend for a 35-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes?

What endocrine therapy, if any, would you recommend for a 35-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes?

What endocrine therapy, if any, would you recommend for a woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative, node-negative tumor?

What endocrine therapy, if any, would you recommend for a woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative, node-negative tumor?

What endocrine therapy do you generally recommend for postmenopausal women with ER-positive, HER2-negative, node-negative tumors?

When you use an aromatase inhibitor (AI) as initial adjuvant therapy, what percent is with each AI?

When you use an aromatase inhibitor (AI) as initial adjuvant therapy, what percent is with each AI?

What percent of your patients on adjuvant AIs have significant arthralgias to the point that you consider discontinuing or switching agents?

What action would you take initially when you consider discontinuing or switching agents with patients who have significant arthralgias?

What percent of your patients on adjuvant AIs have significant vasomotor symptoms to the point that you consider interventions such as SSRI antidepressants?

What action would you take initially when you consider interventions with the patients who have significant vasomotor symptoms?

What endocrine therapy, if any, would you recommend for a 65-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes who completed 5 years of tamoxifen 1 year ago?

What endocrine therapy, if any, would you recommend for a 65-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes who completed 5 years of tamoxifen 1 year ago?

What endocrine therapy, if any, would you recommend for a 65-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes who completed 5 years of tamoxifen 3 years ago?

What endocrine therapy, if any, would you recommend for a 65-year-old woman with a 1.2-cm, Grade II, ER-positive, PR-positive, HER2-negative tumor with 3 positive nodes who completed 5 years of tamoxifen 3 years ago?

Which of the following best describes the action you would take in the following scenarios? A 60-year-old woman was treated 8 years ago at age 52 (postmenopausal) for an ER-positive, PR-positive, HER2-negative, node-negative tumor. She received tamoxifen for 5 years and now presents for routine follow-up, doing well after being off tamoxifen for 3 years.

Which of the following best describes the action you would take in the following scenarios? A 60-year-old woman was treated 8 years ago at age 52 (postmenopausal) for an ER-positive, PR-positive, HER2-negative tumor with 4 positive nodes. She received chemotherapy/ tamoxifen for 5 years and now presents for routine follow-up, doing well after being off tamoxifen for 3 years.

Which of the following would you recommend in the following scenarios? A 61-year-old woman was treated 5 years ago at age 56 (postmenopausal) for an ER-positive, PR-positive, HER2-negative tumor with 4 positive nodes. She received chemotherapy/ anastrozole for 5 years and has tolerated therapy without major difficulties.

Which of the following would you recommend in the following scenarios? An 81-year-old woman was treated 5 years ago at age 76 (postmenopausal) for an ER-positive, PR-positive, HER2-negative tumor with 4 positive nodes. She received chemotherapy/ anastrozole for 5 years and has tolerated therapy without major difficulties.